Company logo

EYPT - EyePoint Pharmaceuticals, Inc.

NASDAQ -> Healthcare -> Biotechnology
Watertown, United States

EYPT price evolution
EYPT
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Current assets
Cash $119.86 $127.78 $138.73 $45.06
Short term investments
Net receivables $13.6 $15.11 $12.33 $9.45
Inventory $4.57 $5.38 $5.59 $5.34
Total current assets $141.78 $151.83 $159.35 $63.12
Long term investments
Property, plant & equipment $2.96 $2.87 $3.04 $3.24
Goodwill & intangible assets $23.36 $23.98 $24.59 $25.21
Total noncurrent assets $26.48 $27 $27.79 $28.6
Total investments
Total assets $168.25 $178.82 $187.14 $91.72
Current liabilities
Accounts payable $6.64 $5.42 $5.86 $4.81
Deferred revenue $15.83 $16.14 $16.32 $16.56
Short long term debt
Total current liabilities $19.93 $16.25 $13.44 $14.89
Long term debt $38.41 $38.25 $40.3 $40.31
Total noncurrent liabilities $55.57 $55.71 $57.99 $58.29
Total debt $38.41 $38.25 $40.3 $40.31
Total liabilities $75.5 $71.96 $71.43 $73.18
Shareholders' equity
Retained earnings -$549.66 -$532.97 -$522.96 -$510.68
Other shareholder equity $0.84 $0.84 $0.84 $0.84
Total shareholder equity $92.75 $106.86 $115.71 $18.54
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Current assets
Cash $45.06 $22.36 $38.93 $17.05
Short term investments
Net receivables $9.45 $11.37 $0.35 $0.25
Inventory $5.34 $2.14 $0.28
Total current assets $63.12 $41.72 $39.91 $17.74
Long term investments
Property, plant & equipment $3.24 $3.44 $0.25 $0.31
Goodwill & intangible assets $25.21 $27.67 $31.36 $0.36
Total noncurrent assets $28.6 $31.25 $31.76 $0.94
Total investments
Total assets $91.72 $72.97 $71.67 $18.68
Current liabilities
Accounts payable $4.81 $4.19 $2.94 $1.02
Deferred revenue $16.56 $0.01 $0.03 $0.05
Short long term debt $0.48
Total current liabilities $14.89 $11.52 $21.66 $5.29
Long term debt $40.31 $50.12 $17.31
Total noncurrent liabilities $58.29 $53.12 $38.32 $0.05
Total debt $40.31 $50.6 $17.31
Total liabilities $73.18 $64.64 $59.98 $5.34
Shareholders' equity
Retained earnings -$510.68 -$465.29 -$363.99 -$310.82
Other shareholder equity $0.84 $0.84 $0.84 $0.83
Total shareholder equity $18.54 $8.33 $11.69 $13.34
(in millions $) 29 Oct 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Revenue
Total revenue $9.01 $7.32 $7.13
Cost of revenue $1.93 $1.39 $2.46
Gross Profit $7.08 $5.93 $4.67
Operating activities
Research & development $5.61 $5.48 $5.21
Selling, general & administrative $11.84 $10.77 $11.59
Total operating expenses $18.06 $16.87 $17.41
Operating income -$10.98 -$10.94 -$12.74
Income from continuing operations
EBIT -$8.63 -$10.93 -$13.64
Income tax expense
Interest expense $1.38 $1.35 $1.83
Net income
Net income -$10.01 -$12.28 -$15.47
Income (for common shares) -$10.01 -$12.28 -$15.47
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Revenue
Total revenue $34.44 $20.36 $2.96 $7.54
Cost of revenue $5.82 $2.69
Gross Profit $28.61 $17.68 $2.96 $7.54
Operating activities
Research & development $17.42 $15.37 $16.18 $14.88
Selling, general & administrative $46.02 $47.71 $13.06 $11.23
Total operating expenses $65.9 $65.54 $29.23 $26.11
Operating income -$37.29 -$47.86 -$26.27 -$18.58
Income from continuing operations
EBIT -$38.14 -$50.62 -$52.45 -$18.48
Income tax expense
Interest expense $7.26 $6.18 $0.72
Net income
Net income -$45.39 -$56.79 -$53.17 -$18.48
Income (for common shares) -$45.39 -$56.79 -$53.17 -$18.48
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Net income -$16.7 -$10.01 -$12.28 -$15.47
Operating activities
Depreciation $0.7 $0.69 $0.69 $0.67
Business acquisitions & disposals
Stock-based compensation $2.47 $1.18 $0.99 $1.26
Total cash flows from operations -$7.79 -$10.54 -$15.1 $5.89
Investing activities
Capital expenditures -$0.13 -$0.03 -$0.19
Investments
Total cash flows from investing -$0.13 -$0.03 -$0.19
Financing activities
Dividends paid
Sale and purchase of stock $0.05 -$0.33 $108.92 $25.12
Net borrowings -$0.04 -$0.04 -$0.02 -$14.64
Total cash flows from financing -$0 -$0.38 $108.77 $10.48
Effect of exchange rate
Change in cash and equivalents -$7.92 -$10.95 $93.67 $16.18
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Net income -$45.39 -$56.79 -$53.17 -$18.48
Operating activities
Depreciation $2.65 $2.6 $1.15 $0.81
Business acquisitions & disposals -$16.78
Stock-based compensation $5.55 $4.57 $2.7 $2.46
Total cash flows from operations -$14.44 -$56.7 -$21.91 -$20.49
Investing activities
Capital expenditures -$0.36 -$0.21 -$0.11 -$0.11
Investments $13.69
Total cash flows from investing -$0.36 -$0.21 -$16.89 $13.58
Financing activities
Dividends paid
Sale and purchase of stock $50.21 $23.04 $42.02 $8.5
Net borrowings -$12.63 $25.94 $18.65
Total cash flows from financing $37.49 $33.86 $60.67 $8.5
Effect of exchange rate $0 $0 -$0.01
Change in cash and equivalents $22.7 -$23.05 $21.88 $1.58
Fundamentals
Market cap $271.03M
Enterprise value $189.58M
Shares outstanding 28.77M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 2.95
Book/Share 3.19
Cash/Share 4.17
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 3.95
Net debt/EBITDA N/A
Current ratio 7.11
Quick ratio 6.88